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ABSTRACT
The delivery of site-specific post-translational
modifications to histones generates an epigenetic
regulatory network that directs fundamental DNA-
mediated processes and governs key stages in de-
velopment. Methylation of histone H4 lysine-20 has
been implicated in DNA repair, transcriptional
silencing, genomic stability and regulation of repli-
cation. We present the structure of the histone
H4K20 methyltransferase Suv4-20h2 in complex
with its histone H4 peptide substrate and
S-adenosyl methionine cofactor. Analysis of the
structure reveals that the Suv4-20h2 active site
diverges from the canonical SET domain configur-
ation and generates a high degree of both substrate
and product specificity. Together with supporting
biochemical data comparing Suv4-20h1 and Suv4-
20h2, we demonstrate that the Suv4-20 family
enzymes take a previously mono-methylated
H4K20 substrate and generate an exclusively di-
methylated product. We therefore predict that
other enzymes are responsible for the tri-methyla-
tion of histone H4K20 that marks silenced
heterochromatin.
INTRODUCTION
Histone lysine methyltransferases generate site-speciﬁc
modiﬁcations in chromatin that signal fundamental
events in transcription, replication and DNA repair
(1,2). Lysine methylation has particular potency in chro-
matin signalling as each lysine can be mono-, di- or tri-
methylated to create discrete binding sites. In turn,
effector proteins contain recognition domains that not
only exhibit a high degree of sequence speciﬁcity but
also are sensitive to the level of methylation (3,4). Only
a limited number of histone lysine side-chains have been
implicated in epigenetic signalling, and for histone H4 in
higher organisms, only the lysine-20 residue is methylated.
In Schizosaccharomyces pombe, all histone H4K20 methy-
lation has been attributed to a single SET domain
methyltransferase, Set9 (5). However, in higher organisms,
multiple enzymes have evolved to control histone H4K20
methylation; established H4K20-speciﬁc methyltrans-
ferases include PR-Set7 and the two Set9 orthologs
Suv4-20h1 and Suv4-20h2, meanwhile histone H4 lysine-
20 monomethyl mark (H4K20me1) demethylase activity
has been demonstrated for PHF8 (6–9).
A fundamental concept that underpins epigenetic
signalling is that each modiﬁcation state should lead to a
speciﬁc biological outcome. In the case of H4K20 methy-
lation, a range of studies have linked H4K20me1 with the
regulation of mitotic regulation and the timing of replica-
tion (10–12) and H4K20me3 with transcriptional silencing
(9,13–15). However, analysis of chromatin isolated from
Drosophila S2 cells and a human HeLa S3 cell line using
mass spectrometry revealed that globally as much as 90%
of histone H4 is di-methylated at lysine-20, making it by
far the most prevalent mark (16,17). Can such a ubiqui-
tous mark have a regulatory role? Direct and preferential
binding of H4K20me2 by 53BP1 links this modiﬁcation to
signalling in double-strand DNA break repair (5,18,19).
Analysis of replication origins using ChIP assay showed
an increased H4K20me2 signal, which correlated with re-
cruitment of the Orc1 protein through its the BAH
domain (20). This recruitment is required for DNA repli-
cation licencing and cell cycle progression. The divergent
biological roles linked to the different H4K20 methyla-
tion states argue for the regulated maintenance of this
mark (21).
Structural, biochemical and cellular studies have
established that PR-Set7 activity is limited to H4K20
monomethylation (10,22,23). However, the knockout of
PR-Set7 inmice leads to a global loss of all threemethylated
forms of H4K20. This implies that in higher organisms
the PR-Set7 enzyme generates H4K20me1, and then subse-
quently other enzymes generate the H4K20me2 and
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H4K20me3 states. In higher eukaryotes, the Suv4-20
proteins have been shown to speciﬁcally methylate
histone H4K20 in vivo (9,17,24,25). Whereas lower eukary-
otes have a single Suv4-20 ortholog, mammals have two
closely related Suv4-20 paralogs, Suv4-20h1 and Suv4-
20h2. A strictly sequential H4K20 methylation model, in
which Suv4-20 enzymes provide the next level of methyla-
tion after PR-Set7, was supported by a study in Drosophila
that usedRNAi silencing to reduce levels of the single Suv4-
20 paralog—a decrease in the levels of bothH4K20me2 and
H4K20me3 was observed along with the accumulation of
H4K20me1 (17). This pattern was replicated in similar ex-
periments that have targeted Suv4-20 protein expression
from ﬁsh to mammals (13,20,26). Suv4-20h1 and Suv4-
20h2 have been shown to preferentially methylate histone
H4K20 on nucleosomes (9), and when overexpressed in
HeLa cells, both proteins localized to pericentric hetero-
chromatin (27). However, in mice, although ubiquitous
Suv4-20h1 expression was observed in both embryo and
adult tissue, Suv4-20h2 expression was low in the embryo
and limited to only a few adult tissue types (26). In the same
study, Suv4-20h1/ mice suffered from developmental
defects that lead to perinatal lethality, whereas Suv4-
20h2/ mice developed normally. Knockout of Suv4-
20h2 but not Suv4-20h1 in mouse embryonic ﬁbroblast
cells resulted in a reduction of H4K20me3 at pericentric
chromatin and telomeres, with concomitant deregulation
of telomere length (13,26). The accumulating evidence
therefore argues that Suv4-20h1 and Suv4-20h2 have non-
redundant roles.
The methylation states of a deﬁned subset of histone
lysine residues determine the site-speciﬁc recruitment of
effector proteins, and it is therefore essential that modiﬁca-
tion enzymes exhibit a high degree of product speciﬁcity.
The SET domain protein lysine methyltransferase family
is responsible for generating different site and methylation
state speciﬁc lysine methylation in histone tails (28,29). The
methylation state speciﬁcity in this family is determined by
a well-documented mechanism termed the phenylalanine–
tyrosine switch (23,30,31). However, a striking feature
arising from sequence comparison of the Suv4-20 proteins
with other SET domains of known structure is that the two
aromatic residues that interact with the target lysineNe and
are the key component of this mechanism are not conserved
(Figure 1A). We have determined the structure of the
ternary complex of Suv4-20h2 with cofactor and histone
H4 peptide and present details of a novel mechanism that
accounts for both substrate and product speciﬁcity in the
Suv4-20 enzyme family.
MATERIALS AND METHODS
Protein expression and puriﬁcation
Murine Suv4-20h1(61-351), Suv4-20h1(61-327), Suv4-
20h2(1-268) and Drosophila Suv4-20(147-393) SET
domain constructs were expressed as Glutathione
S-Transferase (GST)-fusion proteins. Suv4-20h2(1-246),
used for crystallization was expressed with an
N-terminal 6xHis tag. Mutations were generated using
the Quikchange PCR mutagenesis method (Agilent). All
constructs were expressed in Escherichia coli BL21 RIL
cells (Agilent). GST-fusion proteins were isolated from
clariﬁed lysates using glutathione sepharose afﬁnity resin
(GE Healthcare) and separated from the tag by cleavage
with rhinovirus 3C protease. His-tagged proteins were
isolated on HisTrap FF columns (GE Healthcare),
eluted with imidazole, and the tag was removed using
Tobacco Etch Virus (TEV) protease. The protein was
further puriﬁed by ion-exchange chromatography using
HiTrapQ HP columns (GE Healthcare). All proteins
were ﬁnally puriﬁed by size-exclusion chromatography
(Superdex S75, GE Healthcare). The puriﬁcation buffer
was 20mM HEPES (pH 8.0), 500mM NaCl, 5mM
2-mercaptoethanol (2-ME) (pH 8.0).
Crystallization
Crystals were obtained by the hanging-drop method. A
solution of mouse Suv4-20h2(1-246) (175 mM) with
S-adenosyl homocysteine (SAH) (600mM) and a histone
H4 peptide (AKRHRK(me2)VLRD-Y) (600mM), was
crystallized in a condition consisting of 0.1M BisTris
(pH 6.5) and PEG 3350 (6–10%) and improved through
rounds of seeding. Crystals were harvested into a
cryobuffer consisting of the reservoir condition with
20% ethylene glycol and ﬂash-frozen in liquid nitrogen.
The Suv4-20h1(61-327) crystals were grown in a condition
containing 0.1M HEPES (pH 8.0), 10% PEG 10 000,
improved with seeding and harvested into a cryo-buffer
supplemented with 25% glycerol.
Structure determination
Data for the Suv4-20h2(1-246) ternary complex and Suv4-
20h1(61-327) binary complex were collected at the
Diamond Light Source (Diamond Light Source Ltd,
Harwell Science and Innovation Campus, Oxfordshire,
UK) on station I02 and IO4-1, respectively. The reﬂections
were indexed using XDS (32) and reduced/scaled with pro-
grams from the CCP4i suite (33). The Suv4-20h2(1-246)
structure was solved by molecular replacement using the
PHASER package (34) using the coordinates of human
Suv4-20H2 from the binary complex with S-adenosyl me-
thionine (SAM) deposited by the Structural Genomic
Consortium (35) as the search model, PDB code 3RQ4
(36). Difference maps were used to rebuild and extend the
initial model using the Coot molecular graphics package
(37). Iterative cycles of reﬁnement were carried out using
REFMAC (38). The C-terminus of molecule B was poorly
ordered, and all analysis presented refers to molecule A.
The data for Suv4-20h1(61-327) were indexed with the
iMOSFLM package (39) and then solved by molecular
replacement using the PHASER package (34) with the
mouse Suv4-20h2 structure as the starting model. The
coordinates and structure factors for both structures have
been deposited at the PDB with accession codes 4AU7 and
4BUP, respectively.
Methyltransferase assays
Methyltransferase assays were performed using peptide
substrates based on the histone H4 amino terminal
sequence (KGGAKRHRKVLRDNIQ-Y) (Pepceuticals)
662 Nucleic Acids Research, 2014, Vol. 42, No. 1
Figure 1. Intrinsic properties of the Suv4-20 family of SET domain methyltransferases. (A) Sequence alignment of Suv4-20 enzymes with other
structurally characterized SET domains. The numbering is for Suv4-20h2, and the coloured bars indicate the sequence included in the structure
construct and region of SET domain as indicated in (C). Conserved regions are indicated by a grey background. The residues involved in formation
of the lysine channel in blue. Red circles indicate the residues involved in determining the speciﬁcity of Suv4-20h2. (B) Intrinsic methylation
speciﬁcity of H4K20 speciﬁc methyltransferases. Recombinant PR-Set7, mouse Suv4-20h1 and Suv4-20h2 and Drosophila Suv4-20 activity was
measured against peptide substrates based on the H4 sequence with different methylation states at the lysine 20 position. Activities were normalized
to the most active substrate. (C) Stereo representation of the structure of Suv4-20h2 in complex with SAH and histone H4K20me2 peptide—the
subdomains are coloured as indicated in the sequence alignment.
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either unmodiﬁed, mono- or di-methylated in the
underlined position. Two assay formats were used. (i)
An end-point assay that measured the incorporation of
3H labeled SAM into the peptide, which depends on the
separation of the peptide from cofactor using C18 cart-
ridge puriﬁcation (Waters), previously described in (40).
Final reagent concentrations were 0.5mM peptide,
0.5mM SAM (including 0.625 mM 3H SAM), in an assay
buffer of 20mM HEPES (pH 8.0), 50mM NaCl, 2mM
2-ME (pH 8.0). Assays were carried out at 22C for 20min
with a ﬁnal enzyme concentration of 3 mM and raw
Disintegrations Per Minute (DPM) scintillation counter
data converted to nmoles CH3/min/mmol, assuming 1
DPM is equivalent to 5.7 1015 mmoles CH3. This con-
version assumes a radiolabel stock chemical concentration
of 12.5 mM and that there is complete recovery of labeled
peptide. All assays were carried out in triplicate and ex-
pressed as mean±standard deviation. Assays to obtain
kinetic parameters were carried out as mentioned previ-
ously but using peptide concentrations in the range from 0
to 1.5mM. Kinetic analysis of reaction rates was per-
formed using the GraphPad Prism software package
(GraphPad Software, Inc.). (ii) A continuous assay
system, exploiting a coupled enzyme system that
measures the generation of SAH using the
Methyltransferase Colorimetric Kit (Cayman Chemical
Company, USA), was used to follow the time course of
the reaction. The manufacturer’s protocol was modiﬁed as
follows: the ﬁnal SAM concentration was adjusted to
400mM, ﬁnal peptide 200 mM and ﬁnal enzyme concentra-
tion 2 mM. Detection of the ﬁnal H2O2 product of the
coupled enzyme series by 3,5-dichloro-2-hydroxybenze-
nesulfonic acid was measured at 515 nm at 1min intervals
for 150min at 30C. Measurements were performed in
triplicate, the average reading at 10min intervals were
plotted with the standard deviation.
Isothermal titration calorimetry
Isothermal titration calorimetry measurements were per-
formed at 20C, using an ITC 200 microcalorimeter
(MicroCal Inc.). Determinations of the afﬁnity for SAM
were performed by injecting SAM into a sample cell con-
taining Suv4-20h2 (1-268) or Suv4-20h1 (61-351) in
40mM HEPES (pH 7.5), 500mM NaCl and 2mM
2-ME. Binding isotherms were analysed using Origin
Software (OriginLab Corporation).
Microscale thermophoresis
Binding measurements by microscale thermophoresis
(MST) were performed using a NanoTemper Monoloth
NT.115 Instrument (NanoTemper Technologies GmbH).
A peptide corresponding to histone H4K20me1
(KRHRK(me1)VLRD) was synthesised with an
N-terminal ﬂuorescein tag (Pepceuticals) for MST meas-
urements. Measurements were made at 20C using 25%
light-emitting diode power and 40% infrared-laser power
with laser-on time was 30 s and laser-off time 5 s. Multiple
measurements were made for each protein.
RESULTS
Intrinsic substrate and product speciﬁcity of the Suv4-20
family enzymes
Our initial aim was to establish the intrinsic methylation
state speciﬁcity of the Suv4-20 family enzymes, by
measuring the methyltransferase activity of recombinant
constructs containing the SET domain with synthetic
histone H4K20 peptide substrates (Figure 1B). Whereas
PR-Set7 only displays activity with an unmodiﬁed sub-
strate, consistent with it being a monomethylase,
Drosophila Suv4-20 and both mouse Suv4-20h1 and
Suv4-20h2 only show appreciable activity with a peptide
that is monomethylated at H4K20. We conclude that the
Suv4-20 family enzymes require a histone H4K20me1
modiﬁed substrate and then add only a single methyl
group to produce a ﬁnal product of H4K20me2. This
supports the sequential model of H4K20 methylation
but moreover implies that a different enzyme generates
H4K20me3.
To determine the molecular basis of Suv4-20 speciﬁcity,
we obtained crystals of a ternary complex of mouse Suv4-
20h2 (residues 1–246) with the cofactor product SAH and
a short peptide based on the histone H4 sequence and di-
methylated at the K20 position—the product complex. A
structure with a resolution of 2.1 A˚ was solved using a
molecular replacement model of the structure of the
human Suv4-20H2 binary complex with SAM (36). The
overall structure is presented in Figure 1C, and the crys-
tallographic statistics is in Table 1. When compared with
other characterized SET domain proteins, key sequence
features, such as the conserved active site tyrosine
residues, are missing (Figure 1A, red columns).
However, the characteristic SET domain topology is
retained in the Suv4-20h2 structure (Figure 1C).
Signiﬁcantly, the SAH cofactor binds in a surface pocket
on one side of the protein, and the main chain of the
substrate peptide is located in a groove formed by the
packing of the SET-I and postSET regions. Suv4-20h2
has a distinctive N-ﬂanking domain that forms a four-
helix bundle that comprises the entire region N-terminal
to the SET domain, with one pair of these helices packing
against the base of the SET domain.
Suv4-20h2 speciﬁcity is generated by a novel active site
conﬁguration
The methyltransferase mechanism of the SET domain
depends on the formation of a binding channel to
restrain the target lysine in a position optimal for methyl
transfer (28). For Suv4-20h2, this archetypal conﬁguration
is conserved, and the aliphatic portion of the target lysine
side chain is constrained by aromatic side chains (princi-
pally Tyr217) and a main-chain tetrapeptide consisting of
residues Phe160 to Met163. However, features that are
unique to the Suv4-20 family of enzymes explain the mo-
lecular basis of both the requirement for a previously
monomethylated substrate and the lack of activity
observed with di-methylated substrate. Signiﬁcantly, in
the crystal structure, the electron density for the co-
crystallized H4K20me2 peptide was well-deﬁned,
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allowing the unambiguous positioning of both di-
ammonium methyl groups (Figure 2A). One of these,
the ‘product’ methyl, adopts a position pointing towards
the SAH sulfonium ion and represents the situation
directly following methyl transfer, and the environment
of the second ‘substrate’ methyl is critical to determining
the speciﬁcity and is described later in the text.
In previously characterized SET domain methyltrans-
ferases, the restriction to monomethylation is determined
by the presence of two tyrosine residues that interact with
the substrate lysine Ne (22,23,30), shown schematically in
Figure 2B. This has been termed the phenylalanine-
tyrosine switch because in enzymes with a phenylalanine
rather than tyrosine, the hydroxyl/water hydrogen bond
network is lost, and multiple methylation states can be
accommodated. Unusually, in the Suv4-20h2 ternary
complex structure, a broad hydrophobic pocket accom-
modates the substrate methyl group whilst a direct
hydrogen bond to the target lysine Ne is made by
the side chain hydroxyl of Ser161 (Figure 2C).
Accommodating a third methyl group would require
breaking this hydrogen bond and a signiﬁcant rearrange-
ment of the active site. This would be energetically
unfavourable and explains why we do not observe signiﬁ-
cant activity with an H4K20me2 substrate (Figure 2D).
Mutation of Ser161 to alanine resulted in an enzyme not
only with reduced overall activity with respect to the wild-
type but interestingly the speciﬁcity proﬁle was also
altered. Although the Suv4-20h2(Ser161Ala) enzyme did
not methylate either an unmodiﬁed or monomethylated
H4K20 substrate, unlike the wild-type, it methylates a
previously di-methylated peptide (Figure 2D). We attri-
bute the loss of activity with the mono-methylated sub-
strate to the inability to effectively restrain the lysine Ne in
the optimal position for methyl transfer due to loss of
the Ser161 hydroxyl hydrogen bond. We propose that
the signiﬁcant activity observed for the combination
of the alanine mutation and histone H4K20me2 substrate
is likely to arise from better restraint of the more
bulky di-methyl ammonium group in the active site
(Figure 2E).
But what of the requirement for monomethylated sub-
strate? The side-chain of Phe191 occupies the position cor-
responding to the tyrosine-phenylalanine switch residue
described for other SET domain proteins (31). A
detailed comparison of the PR-Set7 and Suv4-20h2
binding sites is shown in Supplementary Figure S1A.
The Suv4-20h2 Phe191 residue is located on a different
region of the protein chain than in other characterized
proteins (Figures 1A and 2A). This residue forms the
centre of the broad hydrophobic pocket that also com-
prises the side chains of Trp174, Ile181 and Ala178. In
contrast to the canonical hydrogen bond network, this
environment effectively excludes water, and therefore
favours the positioning of the methyl group of the
mono-methylated lysine substrate. For the SET domain
to promote efﬁcient methyl transfer, it is essential that
the target lysine-Ne is optimally positioned. Not only
does the Suv4-20h2 pocket accommodate the substrate
methyl but also, as the methyl to Phe Cz distance is only
3.3 A˚, it is likely that this interaction constitutes a CH3-p
hydrogen bond, and this effectively locks the lysine-Ne in
position. Such hydrogen bonds have been described in a
number of systems (41). For a non-methylated lysine in
the Suv4-20h2 active site, this interaction does not take
place, and as a result the lysine Ne is not ﬁxed in the
optimal position for methyl transfer, making the
reaction inefﬁcient (Figure 2D). In other enzymes,
whether a Phe or Tyr is in this position is key to
product speciﬁcity; we were therefore interested in the
effect of substitution of this residue with a Tyr.
Unfortunately, the Suv4-20h2(Phe191Tyr) mutation was
unstable, but we were able to generate the equivalent
mutation in Suv4-20h1. Although stable, the effect of
adding the hydroxyl was a dramatic loss of activity
(Supplementary Figure S1B). For Suv4-20 enzymes
rather than facilitating processivity, the phenylalanine
side chain is part of a pocket that ‘locks’ the substrate
methyl in position and along with Ser161 deﬁnes
product speciﬁcity. Analysis of the sequences of all pre-
dicted human SET domain proteins reveals that contrary
to expectation most do not contain aromatic switch
residues in the conventional positions (Supplementary
Figure S2). This implies that a non-canonical conﬁgur-
ation of the active site may be more frequent than the
currently available subset of characterized proteins
suggests.
Table 1. Crystallographic statistics, collection and reﬁnement
Protein data bank Code Suv4-20h2 ternary
complex (4AU7)
Suv4-20h1 binary
complex (4BUP)
Data collection
Space group P212121 P21
Cell Dimensions
a, b, c (A˚) 37.3, 65.2, 209.5 46.3, 50.0, 129.4
a, b, g () 90.0, 90.0, 90.0 90.0, 92.8, 90.0
Resolution (A˚) 55.3-2.1 (2.13–2.07) 50.0-2.2 (2.28–2.17)
Rmerge 0.036 (0.36)
a 0.09 (0.40)
Mn I/sI 16.9 (2.0)a 13.1 (4.3)
Completeness (%) 97.3 (82.0)a 91.4 (90.2)
Multiplicity 3.4 (2.1)a 6.2 (6.0)
Reﬁnement
Resolution (A˚) 2.1 A˚ 2.2 A˚
No. of reﬂections 25 953 28 977
Rwork
b/Rfree
c 0.19/0.24 0.20/0.26
No. of Atoms
Protein 3677 3995
Ligand/Ion 29 8
Solvent 211 198
B-factors
Protein 32.9 32.0
Ligand/Ion 23.9 29.8
Solvent 44.8 33.1
R.m.s deviations
Bond lengths (A˚) 0.017 0.012
Bond angles 1.88 1.15
aThe average value across the resolution range, whereas that in
parentheses is the value for the highest resolution bin.
bRwork= j jFoj - jFcj j/ jFoj.
cRfree=T j jFoj - jFcj j/T jFoj, where T is a test data set of 5% of
the total reﬂections randomly chosen and set aside before reﬁnement.
Nucleic Acids Research, 2014, Vol. 42, No. 1 665
Do Suv4-20h1 and Suv4-20h2 differ biochemically?
Contrary to expectation, given their divergent biological
roles, we found that both Suv4-20h1 and Suv4-20h2 share
the same intrinsic substrate and product speciﬁcity proﬁle
(Figure 1B), but what of their other biochemical
properties? Comparing the steady state enzyme kinetics
of Suv4-20h1 (61-327) and Suv4-20h2 (1-168) in excess
SAM with respect to peptide concentration revealed a sig-
niﬁcant difference (Figure 3A). The estimated turnover
rates, derived from Vmax were similar—1100 and 1500
nmoles CH3/min/mmole protein, respectively—corres-
ponding to a Kcat of 1.0–1.5min
1. This is in a similar
range to typical rates reported for other SET domain
enzymes in in vitro assays with peptide substrates
(31,42). However, the KM values with respect to
monomethylated peptide substrate varied substantially,
46±1 mM for Suv4-20h1 (61-327) and 510±1 mM
Suv4-20h2 (1-268), respectively. This suggests signiﬁcantly
different substrate afﬁnity, and to quantify this, we used
MST to measure the binding afﬁnity for a ﬂuorescein-
tagged histone H4K20me1 peptide (Figure 3B). The
Suv4-20h1 (61-327) SET domain construct binds the
peptide with a dissociation constant (Kd) of 21±1 mM,
in a buffer containing 300mM NaCl. In the equivalent
buffer, the Suv4-20h2 (1-268) construct binding is ex-
tremely weak (>700 mM) and difﬁcult to evaluate, but in
a buffer containing only 150mM NaCl, the estimated Kd
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Figure 2. Mechanism of speciﬁcity. (A) The Suv4-20h2 active site showing the electron density for the substrate lysine side chain and methyls.
Colours are as described for Figure 1C. (B) Schematic diagram showing the characteristic features of a canonical SET domain monomethylase.
(C) Schematic diagram showing the features that deﬁne speciﬁcity in Suv4-20h2. (D) Activity of the wild-type and Ser161 to Ala mutant of Suv4-
20h2. (E) A speculative schematic diagram illustrating the proposed conﬁguration of a Suv4-20h2(S161A) complex.
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of Suv4-20h2 for peptide was 114±5 mM. Unfortunately,
the recombinant Suv4-20h1 (61-327) construct was not
stable in the lower salt buffer. The sensitivity of peptide
substrate binding of the Suv4-20h2 (1-268) to the buffer
ionic strength is also reﬂected in its methyltransferase
activity (Supplementary Figure S1C).
Recognition of Histone H4 by Suv4-20h2
The molecular basis of the differential substrate afﬁnity of
Suv4-20h1 and Suv4-20h2 is not readily apparent, as the
residues that interact with the substrate are well conserved
(Figure 1A). The histone H4 peptide binds in an extended
conformation to a groove formed at the interface of the
Suv4-20h2 SET-I domain with the postSET and SET-C
region (Figure 3D). The H4 residues (17–24 of histone H4)
pack in a parallel orientation alongside the SET-I domain
strand (residues 162–166) with which it forms a series of
polar and hydrophobic interactions (Figure 3C).
Surprisingly, given the high sequence speciﬁcity of the
enzyme, the majority of polar interactions between H4
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Figure 3. Histone H4 recognition in Suv4-20h1 and Suv4-20h2. (A) Methyltransferase activity Suv4-20h1 and Suv4-20h2 with an H4K20me1
peptide. (B) Binding afﬁnity of Suv4-20h1 (blue) and Suv4-20h2 (red/orange) for histone H4K20me1 peptide using MST. (C) Stereo view
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the binding of the H4 peptide. (E) Schematic of interactions with the H4 peptide and residues in Suv4-20h2.
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peptide and Suv4-20h2 are between main-chain atoms
(shown schematically in Figure 3E). These include
hydrogen bonds between the Lys20, Val21 and Leu22
amides to the carbonyls of Ile162 and Tyr164 in the
SET-I region and Tyr217 from SET-C. A water
molecule bridges interactions between the His18
carbonyl and the main-chain of Asp169, Ser161 and
Ile162. With the exception of Asp24, the peptide side-
chain contacts with the protein are hydrophobic. This is
notable different to the basis of recognition of histone H4
by PR-Set7, where the Arg17, His18, Arg19 and Arg23
side-chains all make hydrogen bonds with the protein
(23). Indeed, a detailed analysis of residue preference at
each position revealed that residues Lys17 and His18 were
key to recognition (43). In PR-Set7, the histone peptide
His18 residue was shown to be critical for recognition, as
it completes the lysine-binding channel and is required for
activity (22,44), but in Suv4-20h2, the H4 His18 is
orientated away from the sprotein core and towards the
solvent. Thus, the determinants of histone H4 sequence
speciﬁcity are not conserved between PR-Set7 and the
Suv4-20 family.
Cofactor binding
In addition to the product complex of Suv4-20h2 with
SAH and peptide, we have determined the structure of a
binary complex of mouse Suv4-20h1 (61-327) paralog with
SAM, at a resolution of 2.2 A˚. The structural conservation
between the two proteins in the region covered by the
constructs is very high, both over the SET domain and
the alpha helical N-ﬂanking region (Figure 4A).
Comparing the environment of cofactor binding in the
complexes reveals that the majority of these interactions
are also conserved (Figure 4B). However, Suv4-20h1 has
an additional hydrogen bond between residue Ser196 and
the SAM carbonyl O30, the equivalent residue in Suv4-
20h2 is a methionine. The consequence of this additional
bond is only a modest increase in afﬁnity for SAM. Using
isothermal calorimetry, in a buffer containing 500mM
NaCl to stabilize the protein, we determined the binding
constants (KD) for mouse Suv4-20h1 (61-327) and Suv4-
20h2 (1-268) to be 11.2±1 mM and 17.2±8 mM, respect-
ively (Figure 4C). Mutating the Suv4-20h2 methionine to
serine resulted in a dissociation constant of 12.5±7 mM,
(Figure 4C and Supplementary Figure S4). Given the
narrow range of binding constants, it is unlikely that
SAM binding represents a physiologically signiﬁcant dif-
ference between the paralogs.
DISCUSSION
An epigenetic signalling network based on the post-trans-
lational modiﬁcation of histones requires that both the
modiﬁcation machinery that generate marks and the rec-
ognition domains on the effector proteins recruited to
these marks exhibit a high degree of speciﬁcity. The
Suv4-20 enzyme family has a distinct speciﬁcity proﬁle,
namely, the requirement for a histone H4 previously
monomethylated on lysine-20 and the production of an
H4K20me2 product. Analysis of the structure of the
Suv4-20h2 product complex reveals that a novel mechan-
ism generates speciﬁcity. The substrate methyl group is
recognized by a hydrophobic pocket, and further methy-
lation is prevented by a tight hydrogen bond between
Ser161 and the substrate lysine Ne. This represents the
ﬁrst description of a SET domain protein in which a limi-
tation to processivity is achieved by a mechanism other
than the canonical phenylalanine-tyrosine switch.
However, sequence analysis indicates that characterization
of further predicted SET domain proteins may reveal a
variety of mechanisms to achieve methyl transfer
speciﬁcity.
As PR-Set7 is limited to production of H4K20me1, it
was proposed that a sequential mechanism exists to
produce the H4K20 methyl marks on nucleosomes in
higher organisms (16). Our structural analysis and sup-
porting biochemical data indicate that the Suv4-20
enzymes add the next methyl to produce the H4K20me2
mark. However the in vitro speciﬁcity proﬁle and the
conﬁguration of the active site are not consistent
with H4K20me3 production. This implies that a third
enzyme, or enzyme family, may be responsible for the
H4K20me3 mark identiﬁed in facultative heterochromatin
and pericentric chromatin. We cannot rule out that a shift
in speciﬁcity in vivo might be induced by a hitherto
unknown mechanism involving the C-terminus of the
protein, recruitment by HP1 or the nucleosomal substrate.
All three methylation states have been attributed to the
related Set9 protein in S.pombe (5), which may indicate
ﬂexibility in the active site in this ortholog. In
Saccharomyces cerevisiae, which had previously been
thought to lack histone H4 methylation and lacks a
Suv4-20 homolog, the H4K20me1 mark has now been
identiﬁed, and this may point to an as yet unidentiﬁed
H4K20 monomethylase family in yeast (45). In
mammals where the sequential addition of H4K20 is
more established, the SMYD3 protein has recently been
shown to have H4K20me2 to H4K20me3 activity (46).
Furthermore, superposition of the SMYD3 structure
with the Suv4-20h2 ternary complex indicates that the
SMYD3 active site has a hydrophobic pocket in an analo-
gous position to that of Suv4-20h2, which we propose
could accommodate one methyl group. In the position
equivalent to the Suv4-20h2 Ser161, there is an environ-
ment that may be able to accommodate the extra methyl
group (described in Supplementary Figure S5). Further
work is required to conﬁrm SMYD3 involvement in
H4K20 signalling, and it is worth noting that the speciﬁ-
city of the majority of SET domain proteins in the human
genome is yet to be determined. It is possible that echoing
the loss of H4K20me1, -me2 and -me3 on deletion of PR-
Set7, the loss of both H4K20me2 and -3 on deletion or
knockdown of Suv4-20h2 could be due to loss of the
required H4K20me2 substrate for a subsequent enzyme
(13,26).
The requirement for two non-redundant H4K20me2-
speciﬁc enzymes in higher organisms is still unclear,
although there are many other SET domain subfamilies
that share speciﬁcity, e.g. the MLL family for H3K4 or
G9a/GLP for H3K9 (47,48). It has been observed that
Suv4-20h1 is more ubiquitously expressed, both in terms
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of tissue type and developmental stage, than Suv4-20h2
(26). Our data indicate that although Suv4-20h1 and
Suv4-20h2 share the same product speciﬁcity proﬁle,
they do show some differences in their peptide binding,
substrate binding and steady-state enzyme kinetic
properties. The Suv4-20h1 steady state properties are
more similar to the Suv4-20 from Drosophila, which like
other less advanced organisms has only a single paralog
(Supplementary Figure S6). Although the Suv-20 paralogs
exhibit high structural conservation over the extent of the
crystallographic constructs, their sequences diverges at the
C-terminus and that Suv4-20h1 has an N-terminal
extension. Presumably, these regions have an important
role in mediating interactions and localization. For
example, it has recently been reported that Suv4-20h2 as-
sociates more stably with pericentric heterochromatin
than its Suv4-20h1 paralog (49). It may be that the differ-
ences we have observed in intrinsic biochemical properties
reﬂects the challenges of the chromatin environment in
which the enzymes function, but further research will de-
termine whether other factors, such as post-translational
modiﬁcations to either substrate or enzyme, or the effect
of partner proteins, may have a signiﬁcant bearing on
activity.
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Figure 4. Analysis of cofactor recognition in Suv4-20 enzymes. (A) Cartoon representation of the structure of the binary complex of mouse Suv4-
20h1 (61-327) with SAM superposed on the Suv4-20h2 structure. The Suv4-20h1 is coloured as in Figure 1C and Suv4-20h2 in grey. A stereo view
of this interaction is shown in Supplementary Figure S4A. (B) Overlay of a stick representation of the cofactor binding interactions observed in
mouse Suv4-20h1 binary complex with SAM and Suv4-20H2 ternary complex with SAH. A stereo view of this interaction is shown in Supplementary
Figure S4B. (C) Determination of SAM binding afﬁnity for Suv4-20h1, Suv4-20h2 and Suv4-20h2(M116S) mutant by isothermal calorimetry. The
binding curves for all three proteins are overlayed for simplicity, and the original data are presented in full in Supplementary Figure S4C. Binding
constants, enthalpy and entropy measurements are summarized below the graph.
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